As of 2024-12-11, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -3.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is -32.37 mil USD. DTIL's TTM EBITDA according to its financial statements is 9.04 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 16.6x | 15.0x |
| Forward P/E multiples | 15.1x - 17.8x | 15.9x |
| Fair Price | 25.51 - 31.00 | 28.22 |
| Upside | 343.6% - 439.2% | 390.7% |
| Date | EV/EBITDA |
| 2024-11-29 | -2.27 |
| 2024-11-27 | -2.43 |
| 2024-11-26 | -2.64 |
| 2024-11-25 | -2.32 |
| 2024-11-22 | -2.30 |
| 2024-11-21 | -2.94 |
| 2024-11-20 | -2.37 |
| 2024-11-19 | -2.38 |
| 2024-11-18 | -2.30 |
| 2024-11-15 | -1.99 |
| 2024-11-14 | -1.93 |
| 2024-11-13 | -1.60 |
| 2024-11-12 | -1.36 |
| 2024-11-11 | -1.35 |
| 2024-11-08 | -1.35 |
| 2024-11-07 | -1.32 |
| 2024-11-06 | -1.33 |
| 2024-11-05 | -1.28 |
| 2024-11-04 | -1.43 |
| 2024-11-01 | -0.81 |
| 2024-10-31 | -1.20 |
| 2024-10-30 | -1.61 |
| 2024-10-29 | -1.54 |
| 2024-10-28 | -1.43 |
| 2024-10-25 | -1.36 |
| 2024-10-24 | -1.26 |
| 2024-10-23 | -1.20 |
| 2024-10-22 | -1.01 |
| 2024-10-21 | -0.98 |
| 2024-10-18 | -0.87 |
| 2024-10-17 | -0.86 |
| 2024-10-16 | -0.81 |
| 2024-10-15 | -1.00 |
| 2024-10-14 | -0.90 |
| 2024-10-11 | -0.89 |
| 2024-10-10 | -0.86 |
| 2024-10-09 | -0.81 |
| 2024-10-08 | -0.70 |
| 2024-10-07 | -0.62 |
| 2024-10-04 | -0.48 |
| 2024-10-03 | -0.37 |
| 2024-10-02 | -0.70 |
| 2024-10-01 | -0.74 |
| 2024-09-30 | -0.86 |
| 2024-09-27 | -0.78 |
| 2024-09-26 | -0.73 |
| 2024-09-25 | -0.71 |
| 2024-09-24 | -0.66 |
| 2024-09-23 | -0.50 |
| 2024-09-20 | -0.31 |